St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Research
Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
Safety in numbers: Advanced biostatistical model resolves questions on vancomycin side effects
Dr. Josh Wolf explains how biostatistics resolved safety questions on preemptive vancomycin for acute myeloid leukemia patients after chemotherapy.
A vaccine to prevent cancer? It’s already here.
Many adolescents fail to get a key vaccination that can prevent cancer. Learn what doctors know about the HPV cancer vaccine.
Five ways to take confirmation bias out of your experimental results
The most important part of research is that you must not fool yourself — and you’re the easiest person to fool.
Blood's oxygen transporter revealed as power source for aggressive pediatric cancer
Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.
ASH 2017: Preliminary results show gene therapy gains in SCID
Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.
ASH 2017: GATA3 in Ph-like acute lymphoblastic leukemia
Jun J. Yang, PhD, shares research presented at ASH that highlights the role the GATA3 oncogene plays in a high-risk subset of acute lymphoblastic leukemia.
ASH 2017: Research on TP53 gene variations featured in first ALL session
Jun J. Yang, PhD, offers highlights of the first ALL session at the American Society of Hematology (ASH) meeting, including his work on TP53. Read more.
Math helps biologist calculate variance of blood progenitor cells
Find out how a researcher applied statistical analysis to chart variance and better understand how childhood leukemia develops.
Sickle cell study on path to improving therapies for children and adults
The Sickle Cell Clinical Research and Intervention Program uses data to determine therapies for children and adults. Learn more.
Brain studies provide treatment clues in unexpected fields
Research shows possible path to restoring critical regions of the brain involved with hearing loss by limiting a neuromodulator in the auditory thalamus.